David Schaffer, PhD

UC Berkeley, 4D Molecular Therapeutics, Professor


What is your current professional status?

Professor

What is your work setting?

Academic Institution

What is your scientific area of research?

AAV gene therapy

Why do you want to be a mentor?

As an educator and mentor, I am committed to fostering the next generation of scientists in our field.

As a mentor, what are you hoping to gain from this experience?

Learning from the next generation of scientists, meeting new people.

How important are the following in the selection of a mentee?
(1 – 5 scale, 1 = most important, 5 = least important)

  • Compatibility of Scientific Specialties: 3
  • Geographic Location: 5 (least)
  • Professional Status / Success: 3
  • Compatibility of Career Path: 3
  • Communication Style: 3

Summarize in a brief paragraph (150 words or less), please provide a biography that describes who you are and what you do in the field of gene and/or cell therapy.

David Schaffer is a Professor of Chemical and Biomolecular Engineering, Bioengineering, and Neuroscience at the University of California, Berkeley, where he also serves as the Director of the Berkeley Stem Cell Center. He received a B.S. from Stanford in 1993 and a Ph.D. from MIT in 1998. He then conducted a postdoctoral fellowship at the Salk Institute for Biological Studies before joining UC Berkeley in 1999. There, he applies engineering principles to enhance stem cell and gene therapies, where his group was the first to apply directed evolution to engineer novel AAV vectors and also develops novel technologies for stem cell therapies.

David Schaffer has received an NSF CAREER Award, ONR Young Investigator Award, Whitaker Foundation Young Investigator Award, American Institute of Chemical Engineers Pharmaceutical and Bioengineering Award, American Chemical Society Marvin Johnson Award, American Chemical Society BIOT Division Young Investigator Award, Biomedical Engineering Society Rita Shaffer Young Investigator Award.

View CV

2019
22nd Annual Meeting
April 29 – May 2 | Washington D.C.
Close